Genetic Mutations Predict SMO Inhibitor Response in SHH Medulloblastoma

Cancer Discovery- United States

doi 10.1158/2159-8290.cd-rw2014-076

Full Text

Abstract

Available in

Categories

Oncology

Date

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Synthesis of SMO Inhibitor PF-04449913

Synfacts
2014English

Mutations and Karyotype Predict Treatment Response in Myelodysplastic Syndromes

American Journal of Hematology
Hematology
2018English

Dual Regulatory Functions of SUFU and Targetome of GLI2 in SHH Subgroup Medulloblastoma

Developmental Cell
BiochemistryDevelopmental BiologyGeneticsCell BiologyMolecular Biology
2019English

Otx2 Promotes Granule Cell Precursor Proliferation and SHH-Dependent Medulloblastoma Maintenance in Vivo

Oncogenesis
Cancer ResearchMolecular Biology
2018English

CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma

Cancer Research
Cancer ResearchOncology
2018English

Intraventricular Meningiomas Frequently Harbor NF2 Mutations but Lack Common Genetic Alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2019English

Presence of Antigen-Specific Somatic Allelic Mutations and Splice Variants Do Not Predict for Immunological Response to Genetic Vaccination

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Correction: Global Genetic Variations Predict Brain Response to Faces

PLoS Genetics
EvolutionEcologyGeneticsMolecular BiologyCancer ResearchSystematicsBehavior
2014English

Distinct Mutations and Pathways Are Linked to Aromatase Inhibitor Response

Cancer Discovery
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy